In solid tumors, IL9 promoted the growth of several types of pancreatic, colitis-associated, colon, or breast cancers by negatively regulating the antitumor function of T cells and promoting the immunosuppressive function of regulatory T cells (8). The gene discussed is IL9; the disease is breast carcinoma.